|
Index of reports
> Cases resulting in a serious event (1344)
> Cases with Pyrexia (91)
Below is the selection of adverse event reports related to Cyclophosphamide that includes cases resulting in a serious event where reactions include pyrexia.
Reports 1 - 25 of 91 Next >>
Adverse event in 54 year old male receiving Cyclophosphamide
Reported by a individual with unspecified qualification on 2007-10-31
Patient: 54 year old male
Adverse reactions / side effects: Jaundice, Graft Versus Host Disease, Lymphopenia, Anaemia, Pyrexia, Generalised Erythema, Diarrhoea, Circulatory Collapse, Neutropenia, Thrombocytopenia, Septic Shock, Leukopenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cyclophosphamide
Adverse event in 25 year old female receiving Cyclophosphamide
Reported by a individual with unspecified qualification on 2007-10-23
Patient: 25 year old female
Adverse reactions / side effects: Dysphagia, Anaemia, Pancytopenia, Pyrexia, Diarrhoea, Staphylococcal Infection, Alopecia, Neutropenia, Asthenia, Pharyngitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Indication: Glomerulonephritis Membranous
Prednisone
Indication: Glomerulonephritis Membranous
Other drugs received by patient: Angiotensin-Converting Enzyme Inhibitor; Anticoagulant; Statin; Recombinant Erythropoietin; Erythropoiesis-Stimulating Agent; Recombinant Granulocyte Colony-Stimulating Factor; Antibiotherapy
Adverse event in 10 year old male receiving Cyclophosphamide
Reported by a physician from United States on 2007-10-10
Patient: 10 year old male, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Pruritus, Pyrexia, Caecitis, Hypokalaemia, Fatigue, Haematocrit Decreased, Photophobia, Thrombocytopenia, Epistaxis, Muscle Spasms, White Blood Cell Count Decreased, Febrile Neutropenia, Varicella, Collapse of Lung, Haemoglobin Decreased, Lower Respiratory Tract Infection Fungal
Adverse event resulted in: hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 28 mg qd x 5 iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-09-08
End date: 2006-09-12
Clofarabine. Mfr: Genzyme
Dosage: 28 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-10-13
End date: 2006-10-16
Clofarabine. Mfr: Genzyme
Dosage: 29 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-11-24
End date: 2006-11-27
Clofarabine. Mfr: Genzyme
Dosage: 30 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-12-26
End date: 2006-12-29
Clofarabine. Mfr: Genzyme
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-01-31
End date: 2007-02-03
Clofarabine. Mfr: Genzyme
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-03-20
End date: 2007-03-23
Clofarabine. Mfr: Genzyme
Dosage: 29 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-05-08
End date: 2007-05-11
Clofarabine. Mfr: Genzyme
Dosage: 28 mg qd iv
Start date: 2007-06-26
End date: 2007-06-29
Cyclophosphamide
Dosage: 615 mg qd x 5 iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-09-08
End date: 2006-09-12
Cyclophosphamide
Dosage: 620 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-10-13
End date: 2006-10-16
Cyclophosphamide
Dosage: 640 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-11-24
End date: 2006-11-27
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2006-12-26
End date: 2006-12-29
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-01-31
End date: 2007-02-03
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-03-20
End date: 2007-03-23
Cyclophosphamide
Dosage: 634 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-05-08
End date: 2007-05-11
Cyclophosphamide
Dosage: 620 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-06-26
End date: 2007-06-29
Etoposide
Dosage: 140 mg qd x 5 iv
Start date: 2006-09-08
End date: 2006-09-12
Etoposide
Dosage: 140 mg qd iv
Start date: 2006-10-13
End date: 2006-10-16
Etoposide
Dosage: 145 mg qd iv
Start date: 2006-11-24
End date: 2006-11-27
Etoposide
Dosage: 150 mg qd iv
Start date: 2006-12-26
End date: 2006-12-29
Etoposide
Start date: 2007-01-31
End date: 2007-02-03
Etoposide
Start date: 2007-03-20
End date: 2007-03-23
Etoposide
Dosage: 145 mg qd iv
Start date: 2007-05-08
End date: 2007-05-11
Etoposide
Dosage: 140 mg qd iv
Start date: 2007-06-26
End date: 2007-06-29
Other drugs received by patient: Acetaminophen; Gabapentin; Senna-S; Miralax. Mfr: Braintree; Methadone HCL; Bactrim. Mfr: Hoffman-LA Roche, Inc.; Voriconazole; Valacyclovir
Adverse event in 44 year old male receiving Cyclophosphamide
Reported by a individual with unspecified qualification on 2007-10-08
Patient: 44 year old male
Adverse reactions / side effects: Adult T-Cell Lymphoma / Leukaemia, Pyrexia
Adverse event resulted in: death
Suspect drug(s):
Cyclophosphamide
Indication: Bone Marrow Conditioning Regimen
Cyclosporine
Indication: Prophylaxis Against Graft Versus Host Disease
Methotrexate
Indication: Prophylaxis Against Graft Versus Host Disease
Prednisone
Indication: Pyrexia
Adverse event in 44 year old male receiving Cyclophosphamide
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-05
Patient: 44 year old male
Adverse reactions / side effects: Graft Versus Host Disease, Adult T-Cell Lymphoma / Leukaemia, T-Lymphocyte Count Increased, Pyrexia, White Blood Cell Count Increased
Adverse event resulted in: death
Suspect drug(s):
Ciclosporin
Indication: Bone Marrow Transplant
Start date: 2004-02-01
Cyclophosphamide
Dosage: 120 mg/kg
Indication: Bone Marrow Transplant
Start date: 2004-02-01
Irradiation
Indication: Bone Marrow Transplant
Methotrexate
Indication: Bone Marrow Transplant
Prednisone
Indication: Bone Marrow Transplant
Adverse event in female receiving Cyclophosphamide
Reported by a individual with unspecified qualification from United States on 2007-10-03
Patient: female, weighing 41.8 kg (92.0 pounds)
Adverse reactions / side effects: Musculoskeletal Pain, Swelling, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 960 mg
Doxil
Dosage: 51mg
Neulasta
Dosage: 6 mg
Prednisone
Dosage: 250 mg
Rituximab
Dosage: 480 mg
Vincristine Sulfate
Dosage: 2 mg
Other drugs received by patient: Cozaar; Darvon; Lactulose; Levothroid; Metoclopramide; Zegerid
Adverse event in receiving Cyclophosphamide
Reported by a individual with unspecified qualification from United States on 2007-10-03
Patient:
Adverse reactions / side effects: Respiratory Rate Increased, Febrile Neutropenia, Headache, Pyrexia, Balance Disorder, Blood Culture Positive, Heart Rate Increased, Dizziness, Bacterial Infection, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 1700 mg
Start date: 2006-12-12
End date: 2007-07-02
Cytarabine
Dosage: 10200 mg
End date: 2007-07-05
G-Csf(filgrastin, Amgen)(614629)
Dosage: 3000 mcg
End date: 2007-07-17
L-Asparaginase(109229)
Dosage: 10000 unit
End date: 2007-07-16
Methotrexate
Dosage: 15 mg
End date: 2007-07-02
Adverse event in male receiving Cyclophosphamide
Reported by a individual with unspecified qualification from United States on 2007-10-03
Patient: male, weighing 71.2 kg (156.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Pancytopenia, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 1380 mg
Doxil
Dosage: 74 mg
Neulasta
Dosage: 6 mg
Prednisone
Dosage: 400 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 690 mg
Vincristine Sulfate
Dosage: 2 mg
Other drugs received by patient: Avodart; Coreg CR; Darvon; Phenergan HCL; Prednisone; Valtrex
Adverse event in female receiving Cyclophosphamide
Reported by a individual with unspecified qualification from Sweden on 2007-10-03
Patient: female, weighing 63.4 kg (139.5 pounds)
Adverse reactions / side effects: Syncope, Palpitations, Pain, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Indication: Breast Cancer
Start date: 2003-07-31
End date: 2003-08-22
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2003-07-31
End date: 2003-08-22
Fluorouracil
Indication: Breast Cancer
Start date: 2003-07-31
End date: 2003-08-22
Other drugs received by patient: Atenolol; Neupogen
Adverse event in 8 year old male receiving Cyclophosphamide
Reported by a individual with unspecified qualification on 2007-10-02
Patient: 8 year old male
Adverse reactions / side effects: Vomiting, Encephalitis, Pyrexia, Drug Toxicity, Grand MAL Convulsion, Mucosal Inflammation, Neutropenia, Hypertension, Blood Creatinine Increased
Suspect drug(s):
CT Contrast DYE
Indication: Computerised Tomogram
Cyclophosphamide
Indication: Burkitt's Lymphoma Stage III
Doxorubicin HCL
Indication: Burkitt's Lymphoma Stage III
Hydrocortisone
Indication: Burkitt's Lymphoma Stage III
Leucovorin Calcium
Indication: Chemotherapeutic Drug Level Above Therapeutic
Methotrexate
Indication: Burkitt's Lymphoma Stage III
Methotrexate
Prednisone
Indication: Burkitt's Lymphoma Stage III
Vincristine
Indication: Burkitt's Lymphoma Stage III
Other drugs received by patient: Ceftazidime; Meropenem; Amikacin; Vancomycin; Acyclovir; Amphotericin B
Adverse event in male receiving Cyclophosphamide
Reported by a physician from Germany on 2007-07-19
Patient: male, weighing 90.5 kg (199.1 pounds)
Adverse reactions / side effects: Pyrexia, Transaminases Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 250 mg/m2, unknown
Indication: Chronic Lymphocytic Leukaemia
Start date: 2003-09-04
Fludarabine Phosphate
Dosage: 25 mg/m2, unknown
Indication: Chronic Lymphocytic Leukaemia
Start date: 2003-09-04
Rituximab
Dosage: 375 mg/m2, unknown
Indication: Chronic Lymphocytic Leukaemia
Start date: 2003-08-26
Other drugs received by patient: Benuron (Germany); Fenistil; Nacl .9%; Pantozol; Zofran
Adverse event in 30 year old female receiving Cyclophosphamide
Reported by a individual with unspecified qualification from Japan on 2007-07-12
Patient: 30 year old female, weighing 41.0 kg (90.2 pounds)
Adverse reactions / side effects: Hypoventilation, Capillary Permeability Increased, Pain, Pyrexia, Liver Disorder, Hyperventilation, Malaise, Chest Pain, Pulmonary Congestion, Pleural Effusion, Tachypnoea, Immunosuppressant Drug Level Increased, Acute Respiratory Failure, Oxygen Saturation Decreased, White Blood Cell Count Decreased, Blood Pressure Increased, Dyspnoea, Chest Discomfort, Vomiting, Brain Natriuretic Peptide Increased
Adverse event resulted in: disablity
Suspect drug(s):
Cyclophosphamide
Dosage: 2000 mg/day
Indication: Stem Cell Transplant
Start date: 2006-06-24
Cyclophosphamide
Dosage: 400 mg/day
End date: 2006-06-25
Irradiation
Indication: Stem Cell Transplant
Sandimmune
Dosage: 2.4 ml/day
Indication: Stem Cell Transplant
Start date: 2006-06-26
End date: 2006-06-26
Sandimmune
Dosage: 10 ml/day
Start date: 2006-06-27
End date: 2006-06-28
Sandimmune
Dosage: 2.4 ml/day
Start date: 2006-06-29
End date: 2006-06-30
Sandimmune
Dosage: 10 ml/day
Start date: 2006-07-01
End date: 2006-07-02
Sandimmune
Dosage: 5 ml/day
Start date: 2006-07-03
End date: 2006-07-03
Sandimmune
Dosage: 2.4 ml/day
Start date: 2006-07-04
End date: 2006-07-05
Sandimmune
Dosage: 5 ml/day
Start date: 2006-07-06
End date: 2006-07-10
Other drugs received by patient: Solanax; Solanax; Solanax; Polymyxin B Sulfate; Takepron; Mycosyst; Iscotin; Ciprofloxacin; Mucodyne; Zovirax; Urso 250; Funguard; Funguard; Funguard; Funguard; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Acyclovir; Acyclovir; Meylon; Meylon; Meylon; Dexamethasone Sodium Phosphate; Zofran; Zofran; Zofran; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Glyceol; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Primperan INJ; Primperan INJ; Uromitexan; Uromitexan; Leuprolide Acetate; Omepral; Fluconazole; Adalat; Solu-Cortef; Solu-Cortef; Solu-Cortef; Solu-Cortef; Haptoglobin; Methotrexate; Methotrexate; Methotrexate; NEO-Minophagen C; Sulpyrine; Sulpyrine; Polyglobin / SPA /; Clindamycin Phosphate; Meropen; Meropen; Meropen; Pazucross; Pentagin
Adverse event in female receiving Cyclophosphamide
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-12
Patient: female, weighing 55.5 kg (122.0 pounds)
Adverse reactions / side effects: Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 950 mg
Doxorubicin Hydrochloride
Dosage: 65 mg
Adverse event in male receiving Cyclophosphamide
Reported by a physician from Germany on 2007-07-11
Patient: male, weighing 90.5 kg (199.1 pounds)
Adverse reactions / side effects: Pyrexia, Transaminases Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 250 mg/m2, unknown
Indication: Chronic Lymphocytic Leukaemia
Start date: 2003-09-04
Fludarabine Phosphate
Dosage: 25 mg/m2, unknown
Indication: Chronic Lymphocytic Leukaemia
Start date: 2003-09-04
Rituximab
Dosage: 375 mg/m2, unknown
Indication: Chronic Lymphocytic Leukaemia
Start date: 2003-08-26
Other drugs received by patient: Benuron (Germany); Fenistil; Nacl .9%; Pantozol; Zofran
Adverse event in female receiving Cyclophosphamide
Reported by a physician from United Kingdom on 2007-07-11
Patient: female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Pyrexia, Aplasia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 430 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2006-02-01
Fludarabine Phosphate
Dosage: 43 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2006-01-02
Rituximab
Dosage: 860 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2006-01-02
Other drugs received by patient: Pantozol
Adverse event in female receiving Cyclophosphamide
Reported by a physician from Germany on 2007-07-10
Patient: female
Adverse reactions / side effects: C-Reactive Protein Increased, Antibody Test Abnormal, Anaphylactic Reaction, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Rituximab
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Adverse event in female receiving Cyclophosphamide
Reported by a individual with unspecified qualification from United States on 2007-07-09
Patient: female, weighing 70.4 kg (154.9 pounds)
Adverse reactions / side effects: Lung Disorder, Haemoglobin Abnormal, Hypoxia, Pyrexia, Cough
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 1080 mg
Doxorubicin Hydrochloride
Dosage: 108 mg
Adverse event in female receiving Cyclophosphamide
Reported by a individual with unspecified qualification from United States on 2007-07-09
Patient: female, weighing 128.7 kg (283.1 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Diarrhoea, Chills, Dizziness, Pyrexia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 1770 mg
Doxorubicin Hydrochloride
Dosage: 118 mg
Prednisone
Dosage: 500 mg
Rituximab (Moab C2b8 Anti Cd20 Chimeric)
Dosage: 885 mg
Vincristine Sulfate
Dosage: 2 mg
Adverse event in male receiving Cyclophosphamide
Reported by a individual with unspecified qualification from United States on 2007-07-05
Patient: male, weighing 109.0 kg (239.8 pounds)
Adverse reactions / side effects: Mucosal Inflammation, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 2330 mg
Cytarabine
Dosage: 40 mg
Dexamethasone 0.5mg TAB
Dosage: 120 mg
Leucovorin Calcium
Dosage: 7689 mg
Methotrexate
Dosage: 3494 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 874 mg
Vincrisitne Sulfate
Dosage: 2 mg
Adverse event in female receiving Cyclophosphamide
Reported by a physician from United Kingdom on 2007-07-05
Patient: female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Pyrexia, Aplasia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 430 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2006-06-22
Fludarabine Phosphate
Dosage: 43 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Rituximab
Dosage: 860 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2006-06-21
Other drugs received by patient: Pantozol; Medication (Unk Ingredient)
Adverse event in 30 year old female receiving Cyclophosphamide
Reported by a individual with unspecified qualification from Japan on 2007-07-03
Patient: 30 year old female, weighing 41.0 kg (90.2 pounds)
Adverse reactions / side effects: Hypoventilation, Capillary Permeability Increased, Pain, Pyrexia, Liver Disorder, Hyperventilation, Malaise, Chest Pain, Pulmonary Congestion, Pleural Effusion, Tachypnoea, Immunosuppressant Drug Level Increased, Acute Respiratory Failure, Oxygen Saturation Decreased, White Blood Cell Count Decreased, Blood Pressure Increased, Dyspnoea, Chest Discomfort, Vomiting, Brain Natriuretic Peptide Increased
Adverse event resulted in: disablity
Suspect drug(s):
Cyclophosphamide
Dosage: 2000 mg/day
Indication: Stem Cell Transplant
Start date: 2006-06-24
Cyclophosphamide
Dosage: 400 mg/day
End date: 2006-06-25
Irradiation
Indication: Stem Cell Transplant
Sandimmune
Dosage: 2.4 ml/day
Indication: Stem Cell Transplant
Start date: 2006-06-26
End date: 2006-06-26
Sandimmune
Dosage: 10 ml/day
Start date: 2006-06-27
End date: 2006-06-28
Sandimmune
Dosage: 2.4 ml/day
Start date: 2006-06-29
End date: 2006-06-30
Sandimmune
Dosage: 10 ml/day
Start date: 2006-07-01
End date: 2006-07-02
Sandimmune
Dosage: 5 ml/day
Start date: 2006-07-03
End date: 2006-07-03
Sandimmune
Dosage: 2.4 ml/day
Start date: 2006-07-04
End date: 2006-07-05
Sandimmune
Dosage: 5 ml/day
Start date: 2006-07-06
End date: 2006-07-10
Other drugs received by patient: Solanax; Solanax; Solanax; Polymyxin B Sulfate; Takepron; Mycosyst; Iscotin; Ciprofloxacin; Mucodyne; Zovirax; Urso 250; Funguard; Funguard; Funguard; Funguard; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Acyclovir; Acyclovir; Meylon; Meylon; Meylon; Dexamethasone Sodium Phosphate; Zofran; Zofran; Zofran; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Glyceol; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Primperan INJ; Primperan INJ; Uromitexan; Uromitexan; Leuprolide Acetate; Omepral; Fluconazole; Adalat; Solu-Cortef; Solu-Cortef; Solu-Cortef; Solu-Cortef; Haptoglobin; Methotrexate; Methotrexate; Methotrexate; NEO-Minophagen C; Sulpyrine; Sulpyrine; Polyglobin / SPA /; Clindamycin Phosphate; Meropen; Meropen; Meropen; Pazucross; Pentagin
Adverse event in 30 year old female receiving Cyclophosphamide
Reported by a individual with unspecified qualification from Japan on 2007-07-03
Patient: 30 year old female, weighing 41.0 kg (90.2 pounds)
Adverse reactions / side effects: Hypoventilation, Capillary Permeability Increased, Pain, Pyrexia, Liver Disorder, Hyperventilation, Malaise, Chest Pain, Pulmonary Congestion, Pleural Effusion, Tachypnoea, Immunosuppressant Drug Level Increased, Acute Respiratory Failure, Oxygen Saturation Decreased, White Blood Cell Count Decreased, Blood Pressure Increased, Dyspnoea, Chest Discomfort, Vomiting, Brain Natriuretic Peptide Increased
Adverse event resulted in: disablity
Suspect drug(s):
Cyclophosphamide
Dosage: 2000 mg/day
Indication: Stem Cell Transplant
Start date: 2006-06-24
Cyclophosphamide
Dosage: 400 mg/day
End date: 2006-06-25
Irradiation
Indication: Stem Cell Transplant
Sandimmune
Dosage: 2.4 ml/day
Indication: Stem Cell Transplant
Start date: 2006-06-26
End date: 2006-06-26
Sandimmune
Dosage: 10 ml/day
Start date: 2006-06-27
End date: 2006-06-28
Sandimmune
Dosage: 2.4 ml/day
Start date: 2006-06-29
End date: 2006-06-30
Sandimmune
Dosage: 10 ml/day
Start date: 2006-07-01
End date: 2006-07-02
Sandimmune
Dosage: 5 ml/day
Start date: 2006-07-03
End date: 2006-07-03
Sandimmune
Dosage: 2.4 ml/day
Start date: 2006-07-04
End date: 2006-07-05
Sandimmune
Dosage: 5 ml/day
Start date: 2006-07-06
End date: 2006-07-10
Other drugs received by patient: Solanax; Solanax; Solanax; Polymyxin B Sulfate; Takepron; Mycosyst; Iscotin; Ciprofloxacin; Mucodyne; Zovirax; Urso 250; Funguard; Funguard; Funguard; Funguard; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Acyclovir; Acyclovir; Meylon; Meylon; Meylon; Dexamethasone Sodium Phosphate; Zofran; Zofran; Zofran; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Atarax; Glyceol; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Heparin Sodium; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Lasix; Primperan INJ; Primperan INJ; Uromitexan; Uromitexan; Leuprolide Acetate; Omepral; Fluconazole; Adalat; Solu-Cortef; Solu-Cortef; Solu-Cortef; Solu-Cortef; Haptoglobin; Methotrexate; Methotrexate; Methotrexate; NEO-Minophagen C; Sulpyrine; Sulpyrine; Polyglobin / SPA /; Clindamycin Phosphate; Meropen; Meropen; Meropen; Pazucross; Pentagin
Adverse event in 38 year old male receiving Cyclophosphamide
Reported by a individual with unspecified qualification from Japan on 2007-06-26
Patient: 38 year old male
Adverse reactions / side effects: Cryptogenic Organising Pneumonia, Viral DNA Test Positive, Acute Graft Versus Host Disease in Skin, Pyrexia, Cough
Suspect drug(s):
Cyclophosphamide
Indication: Cord Blood Transplant Therapy
Cyclosporine
Indication: Cord Blood Transplant Therapy
Cytarabine
Indication: Cord Blood Transplant Therapy
Methotrexate
Indication: Cord Blood Transplant Therapy
Other drugs received by patient: Irradiation
Adverse event in 59 year old female receiving Cyclophosphamide
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-06-26
Patient: 59 year old female
Adverse reactions / side effects: Dyspnoea, Pyrexia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Cyclophosphamide
Indication: Breast Cancer
Start date: 2006-12-05
End date: 2006-12-05
Epirubicin
Indication: Breast Cancer
Start date: 2006-10-03
End date: 2006-11-28
Fluorouracil
Indication: Breast Cancer
Start date: 2006-10-03
End date: 2006-11-28
Methotrexate
Indication: Breast Cancer
Start date: 2006-10-03
End date: 2006-11-28
Neulasta
Indication: Breast Cancer
Start date: 2006-10-03
End date: 2006-11-28
Other drugs received by patient: Ondansetron; Dexamethasone 0.5mg TAB; Amlodipine; Pravastatin Sodium; Perindopril Erbumine; Minocycline HCL
Adverse event in male receiving Cyclophosphamide
Reported by a individual with unspecified qualification from United States on 2007-06-25
Patient: male, weighing 20.2 kg (44.4 pounds)
Adverse reactions / side effects: Blood Albumin Decreased, Pyrexia, Haematocrit Decreased, Refusal of Treatment by Relative, White Blood Cell Count Decreased, Vomiting, Skin Graft, Blood Potassium Increased, Pulmonary Haemorrhage, Haemoglobin Decreased, NO Therapeutic Response, Platelet Count Decreased, Neutropenia, Bradycardia, Cardiac Arrest, Blood Pressure Decreased, Escherichia Infection, Lung Infiltration, Wound Abscess
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 850 mg
Cytarabine
Dosage: 30048 mg
Etoposide
Dosage: 510 mg
G-CSF (Filgrastim, Amgen)
Dosage: 2500 mg
Hydrocortisone
Dosage: 24 mg
Leucovorin Calcium
Dosage: 78 mg
Mercaptopurine
Dosage: 225 mg
Mesna
Dosage: 170 mg
Methotrexate
Dosage: 8475 mg
PEG-L Asparaginase (K-H)
Dosage: 6250 unit
Page 1 Next >>
|
